Priya Kishnani
Pediatrics Residency · Duke University Hospital
Credentials: ·
History
2024–Present- 1983–1987
Medical School
Research
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease
Neurology · 2007 · First of 32 authors · Corresponding · 620 citations
A randomized study of alglucosidase alfa in late-onset Pompe's disease
New England Journal of Medicine · 2010 · 565 citations
The Journal of Pediatrics · 2006 · First of 7 authors · Corresponding · 471 citations
37 papers · 1 as a resident
- GS
28 papers
- HJ
25 papers
- SB
19 papers · 6 as a resident
17 papers
16 papers
16 papers
15 papers
Grants
- 2009–2025
National Institute of Neurological Disorders and Stroke · U54
Project lead · $945.4K · University of Minnesota
- 2019–2022
Identifying Pathogenic Non-Coding Mutations in Rare Mendelian Disease
National Human Genome Research Institute · R21
PI · $433.1K · Duke University
- 1998–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $940.4K · Duke University
- 2001–2004
A Clinical Trial of Donepezil for Down Syndrome
National Center for Research Resources · K23
Contact PI · $336K · Duke University
Clinical trials
- 2024–2034
Rare Glycogen Storage Diseases Natural History Study
Principal investigator · Recruiting
Duke University
- 2022–2024
- 2020–2030
- 2020–2024
Principal investigator · Completed
Duke University